On October 25, improve medical instruments (300030.SZ) released the third quarter report for the year 2024, with the company achieving revenue of 0.421 billion yuan in the first three quarters, a decrease of 10.78% year-on-year; the net income attributable to shareholders of the listed company was -42.5176 million yuan; the non-recurring profit and loss deducted from the net income attributable to shareholders of the listed company was -13.4899 million yuan; with basic earnings per share of -0.14 yuan.
阳普医疗(300030.SZ):前三季度净亏损4251.76万元
Improve medical instruments (300030.SZ): a net loss of 42.5176 million yuan in the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.